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Abstract
Glutaminase C is a key metabolic enzyme, which is unregulated in many cancer systems and believed to play a central role
in the Warburg effect, whereby cancer cells undergo changes to an altered metabolic profile. A long-standing hypothesis
links enzymatic activity to the protein oligomeric state, hence the study of the solution behavior in general and the
oligomer state in particular of glutaminase C is important for the understanding of the mechanism of protein activation and
inhibition. In this report, this is extensively investigated in correlation to enzyme concentration or phosphate level, using a
high-throughput microfluidic-mixing chip for the SAXS data collection, and we confirm that the oligomeric state correlates
with activity. The in-depth solution behavior analysis further reveals the structural behavior of flexible regions of the protein
in the dimeric, tetrameric and octameric state and investigates the C-terminal influence on the enzyme solution behavior.
Our data enable SAXS-based rigid body modeling of the full-length tetramer states, thereby presenting the first ever
experimentally derived structural model of mitochondrial glutaminase C including the N- and C-termini of the enzyme.
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Introduction
Glutaminase C is known as an important protein in cancer
related research [1–3]. Cancer cells have an altered glucose
metabolism known as the Warburg effect. A critical feature of the
changed metabolism is that pyruvate no longer enters the citric
acid cycle, mandating a new source of metabolites to be formed
[4,5]. Glutaminolysis is a key hallmark of cancer cells where
mitochondrial glutaminase (GA) catalyzes the conversion of
glutamine to glutamate [6]. Important materials such as ATP
and nucleotides are produced by further catabolism of glutamate
in the Krebs cycle [5,7,8]. Glutaminase occurs naturally as two
isoforms, namely a liver (LGA) and a kidney (KGA) form [9–11],
as well as a shorter splice variant of KGA referred to as
glutaminase C (GAC) [12]. KGA and GAC are over-expressed
in many cancer cells but for breast, lung and prostate tumor cell
lines only the GAC specie is found within the mitochondria [10].
The two kidney-type GAs are both phosphate activated enzymes
but studies have shown that GAC has a much greater affinity than
KGA towards glutamine at higher inorganic phosphate (Pi)
concentrations [10,12]. Because of GAC’s exclusive location and
kinetic properties it has been suggested that this isoform is the key
enzyme in mitochondrial metabolism in cancer cells, making it
particularly interesting [10,12]. Knowing the protein structure and
its structural behavior in solution is an important step in
understanding the mechanism of the GAC isoform and hence
improve the understanding of cancer metabolism. It has long been
thought that GAC forms a tetramer in order to exhibit activity but
the activation mechanism in vivo is still not fully determined
[13,14]. Very little is known about the protein oligomerization
states and structural changes in solution. However, recently
published crystallographic X-ray structures, determined for a large
fragment of the two kidney-type GAs, reveal the dimer- and
tetramer-interfaces and most of the active site. Furthermore, it has
earlier been shown that a change in the enzyme conformation
occurs in the area of the tetramer-forming interface which keeps a
proposed gating loop to the active site in an open conformation
[15] and it has also been shown that Pi can bind in the active site
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[10]. The structure and mechanism of a large part of the N-
terminal and the C-terminal remain unsolved. However, it has
been suggested by several studies that significant functionalities
reside at the termini [9,10,12,15]. Here we elaborate on the
understanding of the solution behavior of GAC by examining the
oligomerization state of GAC in solution using small angle X-ray
scattering (SAXS), analytical ultracentrifugation (AUC) and multi-
angle light scattering (MALS) techniques to monitor the effect of Pi
titration and increasing protein concentration. We show that the
oligomeric state changes with concentration revealing equilibrium
between a minimum of three species in solution. It was also shown
that the formation of higher oligomers is more pronounced with
addition of Pi. The study reveals great conformational freedom of
the N- and C-termini of GAC and it was demonstrated that the C-
terminal plays a role in the regulation and stabilization of the
tetrameric state. We show a correlation between in vitro enzymatic
activity of GAC and the oligomeric state. Furthermore, we present
a SAXS-derived envelope of the full length GAC in the tetramer
form, including the previously structurally unknown C- and N-
termini. For the SAXS measurements a microfluidic setup for data
collection was applied enabling screening of the solution behavior
of GAC in response to different experimental conditions. Also, the
use of the microfluidic setup enabled the study of a time-
dependent oligomerization effect of the protein.
Results
Microfluidic Sample Environment
For the SAXS study, a microfluidic mixing setup was used. This
provided an optimal experimental setup for screening the solution
behavior of the two examined GAC constructs in response to
relevant changes in the experimental conditions. The setup was
originally developed within the BioXTAS project [16,17] and was
adapted for use on CHESS beamlines. In the CHESS design, the
microfluidic chip was clamped with face-sealing o-rings to a water-
cooled block containing a built-in boroscope for sample visuali-
zation [16,17]. The new chip holders clamping technique made
chip exchange and q-calibration much easier compared to earlier
versions [16,17] (Figure S1–S4 in File S1).
Basic Observations from SAXS Data
Within the cell the first 72 residues of GAC are cleaved when
GA has entered the mitochondria [9], hence we also analyzed
GAC constructs starting from residue 73. SAXS solution
measurements were thus performed from the following two
constructs: GAC wildtype (residues 73–603; GACwt) and a
GAC construct with a truncated C-terminal (residues 73–555;
GACDC). SAXS measurements at different concentration ranges
with and without phosphate addition were carried out using the
microfluidic mixing chip. Selected Pi titration SAXS measure-
ments were performed with and without equilibration over time.
Pi has been shown to activate the GAC enzymatic activity, and
hence, change the oligomeric state. Measurements with and
without equilibration time can potentially show the evolvement of
the process. Based on the scattering data, it is possible to determine
the average radius of gyration (Rg) and average molecular weight
(MW) of the species in solution. In monodisperse systems, it is also
possible to derive the oligomeric state from this value, but for
heterogeneous samples the Rg and MW values rather represent an
average of all scattering particles present in solution. Rg and MW
values are summarized in Table 1 together with the calculated
theoretical values for each construct.
When the protein concentration was increased for GACwt
(GACwtCS) it is seen that the values vary from an average dimeric
state, to beyond an average value of about 6 times the monomeric
state (Table 1 and Figure 1a–b. See also Figure S5 in File S1 and
see data from equilibrated samples in Figure S6 in File S1). The Rg
and MW values are in continuous development with increasing
protein concentration. It is hence concluded that the solution
states investigated exist in a distribution between dimers and larger
species, presumably tetramers and octamers.
It is also observed from the concentration screen of GACDC
(GACDCCS) that the C-terminally truncated construct oligo-
merizes more extensively at higher protein concentrations than the
wt protein (see Figure 1a–b, Table 1 and Figure S5 in File S1)
suggesting that the C-terminal plays a role in the tetramer
formation. This trend is even more evident in the results presented
below.
When titrating Pi into the protein samples (GACwtPS and
GACDCPS), Rg and MW values evolve extensively, hence
revealing further oligomerization (Figure 1c–d, Table 1 and
Figure S5 in File S1). Again, the C-terminally truncated protein
oligomerizes more extensively than the wt protein at otherwise
comparable experimental conditions.
It is also seen that equilibration over time causes the
oligomerization to proceed to even higher oligomeric states
(Figure S6 in File S1). While the presence of even larger species
in solution and hence an even more complex mixture of different
species complicates detailed data analysis of these samples, the
microfluidic setup has allowed detailed analysis of early equilib-
rium states.
Rigid Body Modeling of the GAC Solution Structure
The crystal structures of mouse GAC and human KGA (mGAC
and hKGA) with and without substrate have recently been
published [10,15,18]; however, it has never been possible to
determine the structure of the N- and the C-termini. Here we have
used SASREFMX [19] to identify if the known tetrameric
structure is compatible with the solutions investigated in this
study. In SASREFMX, polydisperse solutions containing partially
dissociated assemblies, can be analyzed by simultaneous fitting of
the scattering data from a concentration range of the protein
species in equilibrium whereby the outcome is a rigid body model
of the whole macromolecule and its volume fraction at each
concentration [19]. From the Rg and MW values we estimated
that the GACwtCS samples include mainly dimeric and tetrameric
protein with the addition of higher oligomers in the most
concentrated samples. Hence, the program was applied on this
dataset both including and excluding the highest concentration
measurements. The resulting tetrameric model including all data
yielded chi values ranging from 1.1 to 2.9, whereas, by excluding
the highest concentration, the highest chi value was reduced to
1.4. The typical models calculated in both scenarios were rather
similar (see Figure S7 in File S1). The volume fractions of dimers
and tetramers are shown in Figure 2a. The models calculated
excluding the highest concentration data curves were preferred
since the high concentration scattering curves could potentially
include structural information that was not present in the lower
concentration scattering curves. The low-resolution solution
structure and fits to the experimental data for three of the seven
included scattering curves are shown in Figure 3 (SASREFMX fits
to all data curves included in the modeling are shown in Figure
S13 in in File S1). Volume fractions and translations are listed in
Table S1 in File S1 for both described models. See materials and
methods for details.
Glutaminase C Solution Behavior
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MALS and AUC Analysis of the Solution Oligomer
Distribution
To verify the presence of different oligomeric species in
equilibrium, as suggested by the basic SAXS analysis, we next
subjected our proteins to MALS and AUC studies. Indeed the
presences of several species were verified by both methods. Due to
differences in experimental conditions when applying the different
methods, results are not exactly quantitatively comparable. Within
the concentration range, measurable by MALS (significantly lower
than for the SAXS analysis for this protein system), three different
species could be detected, but no significant changes in the
distribution of oligomers were noticeable as a function of the
protein concentration (see Figure 4a). Scattering corresponding to
99% of the volume fraction derived from a species with an RMS
radius (Rz) of approx. 70 A˚, which could represent a tetramer. The
theoretically calculated hydrodynamic radius (Rh) of a tetramer in
Figure 1. SAXS data and basic biophysical parameters. a) The microfluidic-mixing chip was applied to collect SAXS intensity curves for protein
concentration dilution series of GACwt and GACDC. The intensity curves plotted are background subtracted and normalized with concentration. The
blue dashed lines show the data for the GACwt and the solid orange lines show the data for GACDC. b) MW and Rg determinations from the SAXS
data for the protein concentration screen data are plotted against protein concentrations. The solid lines show the Rgvalues and the dashed lines
show the MW values. c) The microfluidic-mixing chip was applied to collect SAXS intensity curves for phosphate titration series of GACwt and GACDC.
The protein concentration was kept constant at 30.7 mM for GACwt and the protein concentration was kept constant at 33.8 mM for GACDC. The
intensity curves plotted are background subtracted and normalized with concentration. The blue dashed lines show the data for GACwt and the solid
orange lines show the data for GACDC. d) MW and Rg determinations from the SAXS data for phosphate concentration screen are plotted against
protein concentration.
doi:10.1371/journal.pone.0074783.g001
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solution is 77 A˚; the data hence suggest that the protein largely
exists in a tetrameric state in the investigated concentration range.
The other oligomeric species present (from small volume fractions
with estimated Rz values of 194 A˚ and 346 A˚ respectively) could
indicate the presence of 16mers and higher oligomers (16mers
theoretical Rg = 186.5 A˚) forming by association in an elongated
direction. The GACwt phosphate screen (GACwtPS); Pi concen-
trations from 0–100 mM, with an effective protein concentration
constant at ,5 mM, (see Materials and Methods for details)
revealed a sudden increase in Rz after 25 mM Pi (see Figure 4b).
Monomeric or dimeric protein are not detectable in any of the
samples investigated, rather an intermediately sized species with
Rz = 65 A˚, i.e. in the vicinity of the theoretical Rh value for the
tetrameric species (77 A˚). Again a larger oligomer with Rz = 217 A˚
is detected, and a small amount of a multimer with Rz = 545 A˚
(MALS raw data are shown in Figure S8 in File S1).
Using AUC, a distribution between different oligomeric species
is also observed, where the concentrations similar to those used for
the SAXS experiments were used (See Figure 4c). The major peak
observed at an Sw20 (S value, corrected for buffer density and
viscosity at 20uC) of approximately 4.5 S corresponds to a MW of
a dimer. The smaller peaks observed at approximately 3.5 S and
6 S correspond to that of a monomer and tetramer, respectively.
Expected S, Rg values and Rh values were estimated using the
HYDROPRO program, confirming the presence of predomi-
nantly dimer species with smaller fractions of monomer and
tetramer [20]. Furthermore, the predictions suggest that it is the
more compact dimer (instead of a dimer forming in the elongated
direction) that exists in equilibrium with tetramer and monomer in
solution (See Figure S9 in File S1 for an illustration of a tetramer
structure, the possible dimers and the estimated S, Rg values, and
Rh values). As the protein concentration is increased the
population of dimer increases significantly whereas only a small
Table 1. Solution concentrations and basic biophysical parameters derived from the SAXS data.
Estimated MW (kDa) Estimated Rg (A˚)
I(0) Guinier App. OLIGO EOM Guinier App. OLIGO EOM
GACwt 13.7 18.660.2 122 188 197 5260.6 57 50
conc (uM) 22.2 44.960.2 181 205 204 5460.3 61 52
30.7 65.860.2 192 191 208 5560.2 60 51
39.3 88.660.2 202 210 245 5660.2 62 58
49.5 121.560.2 220 211 246 5660.1 61 59
58.1 143.860.3 222 215 230 5660.1 62 57
66.6 161.460.3 217 213 263 5860.1 62 50
73.4 175.860.3 214 212 262 5860.1 62 59
Phos. 0 86.660.3 248 237 6360.6 73
Conc.(mM) 25 62.960.2 225 224 6260.3 64
50 74.260.2 236 180 5760.2 72
60 86.060.3 291 212 6560.2 94
80 100.960.3 280 249 6660.1 90
100 86.660.3 324 288 7660.1 104
GACDC 24.5 42.060.2 169 210 204 5460.3 65 49
Conc(uM) 33.9 63.160.2 184 212 176 5360.2 66 48
43.3 98.460.2 224 258 209 5860.2 74 54
54.6 138.360.2 250 286 208 5960.2 78 55
64.0 169.760.3 262 312 237 6360.2 81 61
73.4 199.160.3 268 329 255 6360.1 81 62
82.8 234.160.4 279 350 249 6660.1 85 64
97.9 269.260.4 271 365 256 6960.1 87 66
Phos. 0 71.760.3 199 243 6260.4 71
Conc.(mM) 25 71.060.5 197 251 6260.9 72
50 95.660.9 265 212 7961.4 73
60 111.861.0 310 373 9661.3 88
80 128.361.8 356 388 10362.4 90
100 334.667.0 277 425 15863.8 91
Forward intensity scattering, the I(0) values, are estimated from data un-scaled for concentration. Guinier Approximate MW (Guinier App MW) and Guinier App
Rg are estimated from the forward scattering. OLIGO MW and OLIGO Rg estimates are derived from OLIGOMER program analysis. EOM MW and EOM Rg are
estimates generated from EOM analysis. Theoretical MW for glutaminase C wild type construct is 234.20 kDa for tetramer and 117.10 kDa for dimer. Theoretical Rg is
57.50 A˚ for tetramer and 41.64 A˚ for dimer. The theoretical radius of Gyration for an octamer and a 16mer growing in an elongated direction is 94.7 A˚ and 186.5 A˚
respectively. Theoretical MW for glutaminase C construct with truncated C-terminal is 103.24 kDa for dimeric and 318.72 kDa for hexameric protein. Rg for GACwt and
GACDC are estimated to be very similar within the accuracy of SAXS data.
doi:10.1371/journal.pone.0074783.t001
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Figure 2. SAXS based analysis of solution systems flexibility and oligomeric states. a) Bar plot depicting the EOM estimated oligomer
distribution (marked with E in legend), the SASRFMX distribution of dimers and tetramers (marked with S) and the OLIGOMER analysis estimated
distribution (marked with O) of GACwt at the analyzed protein concentrations given on the x-axis in mM units. b) Bar plot depicting the EOM
Glutaminase C Solution Behavior
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population of tetramer is observed also at higher protein
concentrations (23 and 31 mM starting concentration). Hence,
within the effective concentrations obtained during the sedimen-
tation velocity experiments, mainly an monomer-dimer equilibri-
um is observed. Despite the fact that similar oligomeric species are
observed when using AUC, the oligomeric distribution observed is
different when compared to the other methods. A possible reason
for this observation is that the time taken to perform the AUC
experiments is much longer than for the other methods, allowing
further aggregation of the tetramer into much larger oligomers.
Alternatively, HYDROPRO fails to take into account the effect of
the observed significant flexibility, yielding poor estimates of the
theoretical S-values. Hence, the observed distribution of species in
the AUC experiment may well be completely in accordance with
the SAXS experiments. Changes were observed in the distribution
of the three different species detected.
SAXS Based Analysis of Dynamic Structural Ensembles
and Oligomers in Solution
The SASREFMX rigid body modeling analysis confirmed that
the previously known tetrameric structure with addition of the N-
and the C-termini is supported by our SAXS data. Therefore, we
proceeded to a more thorough approach for describing the flexible
C- and N-termini using the program EOM [19,21]. In accordance
with experimental data, the program selects ensembles of
theoretical scattering curves generated from very large pools of
structures, where the assumed flexible parts of the protein are in
random conformations. The selected pool of structures does not
describe the actual combination of specific structures that is found
in the solution, but rather a collection of structures representative
of the solution state in size and conformation. As a complementary
approach to the SASRFMX and EOM analysis we also employed
the program OLIGOMER to evaluate the quaternary structure
distribution [19,22]. From a predefined set of structures of
different size and shape, the program calculates a linear
estimated oligomer distribution (marked with E) and the OLIGOMER analysis estimated distribution (marked with O) of GACDC at the analyzed
protein concentrations given on the x-axis in mM units. For a) and b) the EOM-derived distribution was estimated by taking the structures giving the
best fit to the experimental curve. c) Bar plot showing the derived oligomer distribution given by OLIGOMER analysis as volume fractions for GACwt
phosphate titration screen. d) Bar plot showing the OLIGOMER distribution as volume fractions for GACDC phosphate titration screen. e) EOM
analysis of concentrations screen of GACwt. Rg distribution of GACwt corresponding to the pool of structures (given pool of dimers, tetramers and
octamers is shown in green). f) EOM analysis of concentrations screen of GACDC. Rg distribution of GACDC corresponding to the pool of structures
(given pool of dimers, tetramers and octamers is shown in green).
doi:10.1371/journal.pone.0074783.g002
Figure 3. GlutaminaseC tetramer 3D low-resolution solution structure. Rigid body model of GACwt tetramer shown from three different
orientations. The 3D structure was calculated with the SASREFMX program using a combination of the atomic resolution structure (pdb code
3ss3.pdb) and the GACwtCs data. The areas shown in pink and green are flexible regions and the rigid body model is therefore only an illustration of a
structure that could typically be found in the solution. The plot in the right lower corner shows the SASREFMX fit to the experimental data for three of
the in total eight scattering curves included in the calculation. The model can be compared to a model calculated while excluding the highest
concentration data (Figure S7 in File S1).
doi:10.1371/journal.pone.0074783.g003
Glutaminase C Solution Behavior
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combination of the corresponding scattering curves, in accordance
with the experimental data. This hence yields the volume fractions
of each oligomeric species. It should be noted that, in contrast to
the EOM and SASREFMX approaches, the OLIGOMER
program only uses a few parameters for the best fit optimization
to the SAXS data [19,21] and suits here as a tool to cross-validate
the results obtained with molecular modeling. The three different
approaches to SAXS data analysis will in concert address the
different degrees of freedom in the complex protein samples.
Analysis of Ensembles and Oligomers in Solution for
GACwt
According to the basic SAXS analysis, MALS and AUC
analyses, a distribution of primarily smaller oligomers exists when
screening the solution behavior of GACwt protein at different
concentrations, however complemented by a small fraction of
larger oligomers (Figure 2a, e, Table 1 and Figure S13 in File S1).
Earlier reports based on TEM images [23] and our own TEM
data (see Figure S10 in File S1) indicate that higher order
oligomers form as elongated species. Hence, a tentative octamer
and a hexadecamer model were constructed in accordance with
what was learnt from the TEM measurements (see Figure S11 in
File S1). Since the program EOM [19,21] allows to model
Figure 4. MALS and AUC based analysis of solution oligomeric state. a) MALS data for GACwt displaying mass fractions of oligomeric
species in the protein solution in the protein concentration range 1.4 mM to 9.7 mM as detected on MALS with estimated Rz values (RMS radius) given
on the x-axis. Elution concentration of the dominant peak is given in the legends. The error bars represent calculated fitting errors. b) MALS data for
GACwt displaying phosphate dependent changes in protein oligomeric state. Mass fractions of species as detected on MALS with estimated Rz values
given on the x-axis. Protein concentration was kept constant at 31 mM for all samples. The error bars represent calculated fitting errors. c) AUC
sedimentation velocity data for GACwt construct showing a protein concentration dependent distribution of oligomeric states. The obtained
continuous size distributions are plotted against the S values, corrected for buffer density and viscosity at 20uC (Sw20), for the different protein
concentrations as shown in the figure. d) Inorganic phosphate dependence of the activity of GACwt. The data is shown as mean +/2 SD from three
independent experiments. The line through the data points is drawn by inspection.
doi:10.1371/journal.pone.0074783.g004
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oligomers, we included dimers, tetramers and octamers in the
starting pool. Good fits to the experimental data were obtained
with chi values ranging from 1.2 to 1.7 (See Figure S12 and S13 in
File S1). The selected ensembles containing dimers, tetramers and
octamers suggest that compact conformations are never or rarely
selected. It can hence be concluded that the samples contain
significantly flexible and rather extended species of dimers,
tetramers and octamers. Figure 2a depicts the relative distribution
of dimers, tetramers and octamers as given by the EOM analysis
(plots showing the distribution including standard deviation are
shown in Figure S14 in File S1). Representative structures were
carefully chosen (see Materials and Methods for details) among
those most frequently selected by EOM and used as a starting pool
for the complementary analysis with the program OLIGOMER
for the GACwt data. The results obtained hence crosscheck the
oligomer distribution given by EOM and SASREFMX. Within
the given concentration range the analysis of GACwtCS data
reveals a development in the distribution of oligomers where the
level of tetramers increases with concentration up to 85% before
the formation of octamers finally slightly depletes the tetramer
pool. Accordingly, the presence of dimers decreases as the
concentrations are increasing (Figure 2a and Table 1. See also
Table S2 in File S1). Fits between the experimental data and
selected EOM generated structures are shown in Figure S12 in
File S1 and furthermore a plot is shown in Figure S13 in File S1
showing the fits obtained from EOM, OLIGOMER and
SASREFMX analysis of the GACwtCs data. The chi values
range from 1.3 to 2.3 (the highest chi values were found for the
samples with the largest fraction of oligomers larger than
tetramers). In the analysis no monomers are selected, consistent
with the EOM result.
The overall parameters extrapolated using SAXS, MALS and
AUC data from the GACwt phophate-screen revealed the
presence of significant amounts of higher order oligomers and
EOM analysis can therefore not be carried out. A manually built
hexadecamer model was included in the OLIGOMER analysis.
The analysis shows a shift in the solution distribution between
25 mM and 50 mM Pi, in accordance with the previous MALS
analysis (Figure 2c and Table 1. See also Table S2 and Figure S12
in File S1). However, above 50 mM Pi increasing volume fractions
of octamers are selected with a maximum of 38% at 80 mM Pi.
The quality of the obtained fit to the experimental data decreases
when octamer fractions are selected, indicating that other types of
conformations could be present. The chi values range from 1.3 to
2.2.
Analysis of Ensembles and Oligomers in Solution for
GACDC
The EOM analysis resulted in chi values ranging from 1.2 to 2.5
(Figure 2f, Table 1 and Figure S15 in File S1), with the
discrepancies of the fits being most pronounced for scattering
curves from high protein concentration samples (Figure S12 in File
S1). Consequently a broad selection of Rg values is seen for dimers,
tetramers and octamers, in the range of the larger Rg values within
each random pool. Therefore, as it was observed for the wtCS
data, it can be concluded that both dimer, tetramer and octamer
conformations are significantly flexible and overall in an extended
conformation. Also, the higher oligomer (octamer) conformation is
only approximate (as seen by the increasing chi values at higher
concentrations of Pi). The bar plot in Figure 2b depicts the
percentage distribution of dimers, tetramers and octamers. A mix
of dimers and tetramers is selected for the lower concentrations
while above 64 uM mainly tetramers and octamers are selected.
When compared to the results from GACwtCS analysis, GACDC
shows a significantly more rapid concentration dependent shift
between the different oligomers. This is in line with the overall
parameters extracted from the SAXS experimental curves.
The OLIGOMER analysis for GACDC results in a continuous
shift in the distribution of dimers, tetramers and octamers in the
solution (See Figure 2b and Table 1. See also Table S2 in File S1).
This confirms and elaborates on the result from the EOM analysis
and from the basic SAXS analysis. The appearence of octamers
starts at a lower concentration compared to what was seen for
GACwtCS. Again, the chi values are high, and based on the
MALS analysis, it is suggested that the discrepancies in the fits are
due to the presence of even larger species in solution (see fits in
Figure S12 in File S1).
During the phosphate screen the basic SAXS data analysis
shows a rapid shift to very large oligomers. For the OLIGOMER
analysis the earlier mentioned selected structures were included
(the structures selected among the most frequent structures chosen
by EOM in the GACDCCS) (Figure 2d and Table 1. See also
Table S3 in File S1). As for the GACwtPS a shift in the
distribution is seen when increasing from 25 mM to 50 mM
inorganic phosphate in the solution. Below 50 mM Pi primarily
dimers and tetramers are found in the solution. Above that,
octamers and 16-mers (and assumingly even higher oligomers) are
present. This shift correlates very well with the shift seen in the
parameters obtained from the basic SAXS analysis. When
comparing the oligomer distribution derived from EOM analysis
of the four datasets the results of the two pi screens seams more
coherent than the results of the two concentration screens. As
larger oligomers are induced by the presence of phosphate and
hence larger changes in the oligomer distribution are seen over the
analyzed Pi concentration ranges, we speculate that this enables
the EOM program a more precise estimation of the oligomer
content in the different the SAXS.
Correlation of Protein Activity and Oligomeric State in
Solution
The catalytic properties of GACwt and GACDC were analyzed
in correlation with the protein concentration. For most of the
analyzed concentration range, the activity level of GACDC was
lower than that of GACwt. The glutamine hydrolytic activity of
GACwt and GACDC was measured as a function of increasing
protein concentration. There was an increase in activity as the
protein concentration was raised from ,50 nM to 1 mM, and the
activity of GACwt is consistently higher than that of the GACDC
construct. The trend seen for the GACwt construct is in agreement
with the results obtained by Cassago et al. using a similar construct
(aa 128–603) [10]. See Figure S17 in File S1.
The GACwt ability to catalyze L-glutamine conversion in
correlation with the concentration of Pi was also studied. The data
indicate that Pi induced oligomerization results in a tremendous
increase in the activity of GAC, reaching a near saturation around
50 mM Pi. The activity of GACwt (50 nM) showed a substantial
increase as the concentration of Pi was raised to 100 mM. The
specific activity of the enzyme increased from 5 moles of glutamine
hydrolyzed/sec/mole of enzyme in the absence of Pi to 70 moles
of glutamine hydrolyzed/sec/mole of enzyme in the presence of
75 mM Pi. These findings are in good agreement with earlier
published data by Cassago and co-workers for a similar construct
used (aa 128–603), demonstrating that our construct (GACwt: aa
72–603) shows the same enzymatic behavior despite the elongated
N-terminal [10], see Figure 4d.
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Discussion
By applying a microfluidic setup for the SAXS data collection, it
was possible to screen the solution behavior of GAC in response to
different experimental conditions. It is also possible to study
solution behavior with SAXS using off-chip mixing and standard
SAXS data collection, but here, in addition, we observe a time-
dependent oligomerization effect. It is clear that the oligomeric
state evolves over time, hence the effect of both protein
concentration and Pi-concentration in particular are more easily
analyzed from the microfluidic based data, compared to off-chip
measurements. After equilibration over longer time-periods, the
oligomeric state is so large that decomposition of the data into
scattering data derived from smaller species is complicated or even
impossible. This is evident also from the complementary data from
AUC and MALS analyses.
MALS and AUC data were included in the study as a
supplement to the SAXS data. Using these two techniques a
distribution between a number of different oligomeric species were
observed. The differences in the sizes of the oligomeric species
present in solution, that are estimated by the different methods,
can be understood when considering the experimental differences
during the data collection. The MALS data confirmed the
existence of a solution distribution between small and rather large
oligomers. MALS is typically applied using protein concentrations
that are significantly lower than those applied during SAXS, due
to the dilution effect from the gel filtration integrated with the
MALS technique. In the present study, the concentrations
investigated were hence significantly lower during the MALS
analysis than during the SAXS analysis. In either case MALS data
reveal the presence of a relatively large fraction of a larger
oligomeric species (assumingly tetramers in the concentration
screen, and even larger species in the phosphate screen). Neither in
the AUC nor the SAXS analysis, comparable fractions of very
large species is detected. During the MALS analysis the protein
experiences significant contact with very large surface areas on the
column material. In some cases this is known to influence the
oligomeric distribution, which hence may be the case here. In our
SAXS analysis we clearly reveal that equilibration causes further
oligomerization (Figure S6 in File S1), underlining the importance
of applying a microfluidic setup for the SAXS data analysis. The
shifts in oligomeric states in response to the experimental changes
are very pronounced both in the SAXS and the AUC data. We
hypothesize that the shift to lower oligomers is induced by the
tetramer conformation being more prone to aggregation during
the relatively lengthy AUC experiment, explaining the absence of
significant amounts of tetramer in the AUC experiment. An
alternative explanation would be that the calculated sedimentation
coefficients only poorly reflect the experimental sedimentation of
the highly flexible macromolecules. Hence, solution equilibria are
potentially sensitive to the method specific experimental conditions
during measurements, and also here the use of the microfluidic
SAXS setup has played an important role. When applying SAXS
analysis, the solution equilibria are not disturbed, since there is no
physical separation of the individual oligomeric species (as is the
case with both AUC and particularly MALS by centrifugation and
chromatography respectively). Hence, SAXS enables analysis of
the detailed differences between individual measurements in
response to changes in the experimental conditions, which may
be derived from the information rich data. In this study, the
comparison of the solution state by applying three different
methods, underscores the importance of using complementary
methods for the analysis of complex solutes.
When comparing the actual estimates of Rg of individual
oligomeric species from the different methods, there is a slight
variation, but overall the obtained estimates agree surprisingly
well. The clear observation from the SAXS data, revealing that the
N- and C-termini of GAC are in random and extended
conformations may explain why the different methods show
slightly different estimates of the overall size of the molecules.
Importantly, however, in spite of differences in the quantitative
estimate of species that exists as a distribution between different
oligomeric species is confirmed by all three methods.
It can be questioned, whether the in vitro observations, revealing
the existence of significant amounts of oligomers larger than
tetramers (observed by TEM, SEC-MALS and SAXS) have direct
biological significance. All three methods demonstrated pro-
nounced oligomerization for both constructs, and relatively more
so with addition of Pi. An earlier study used AUC to show that
KGA forms tetramers and higher oligomers when Pi is added to
the solution, in accordance with our results [24]. MALS and
SAXS data analyses of the Pi titration are consistently showing a
shift in oligomeric state at Pi concentrations above 25 mM, i.e.
corresponding to high protein:Pi ratios. It has earlier been
reported that enzymatic activity is sensitive to addition of Pi
[10,12,25]. Our data elaborate on this observation, revealing a
close connection between enzymatic activity, Pi concentration and
the oligomeric state. The results evidently indicate a very low
affinity to Pi. Exactly how Pi effects the oligomerization or the
enzymatic activity and its biological relevance is not conclusive
from this study. A recent study elaborating on the Pi effect on
GAC structure has suggested that higher Pi concentrations could
be expected in cancer cells and hence regulate GAC activity [10].
Also, it could be speculated that the proteins binding of Pi
somehow changes the flexibility of the gating loop. Indeed, it has
previously been shown that the enzyme changes conformation in
the area of the tetramer-forming interface, keeping a proposed
gating loop to the active site in an open conformation [15] and it
has also been shown that Pi binds in the active site [10]. In
addition, it has earlier been shown that KGA activity is regulated
by phosphorylation [15]. A different study shows that GAC
enzyme activity can be inhibited by binding of inhibitors to the
dimer interface [25]. Likewise, as an alternative to the loop-
regulation theory, it may be speculated, that the negatively
charged inorganic phosphate occupies positive patches on the
protein surface, thereby overall shielding for repulsions between
positively charged amino acids which otherwise would diminish or
prevent the dimerization and/or tetramerization. The most
prominent site of tetramerization is the helix including amino
acids 394–404 and indeed there are positively charged amino acids
flanking both ends of this helix. Likewise, positively charged
residues can be identified in the vicinity of the dimerization
interface (e.g. Arg459 on one protomer, and Lys544 on the other).
The suggestion that inorganic phosphate diminishes repulsive
charge effects remains speculative, yet provides a plausible and
simple explanation for the observations reported here.
As is observed from the SAXS data collection by applying the
microfluidic setup, there is an observable time dependency on the
oligomeric solution state. Hence, the ability to measure SAXS data
at early time-points and thus prior to extensive oligomerization
enables much more detailed analysis. This has made it possible to
obtain a structural description of the different lower oligomeric
states, together with a structural characterization of the N- and C-
termini.
The three naturally occurring isoenzymes have a high sequence
similarity, apart from differences in the distinct C-terminal
sequences, suggesting significant functionality of the C-terminal
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[12,14]. In this study our analysis of SAXS solution data revealed
great conformational freedom of the N- and C-termini of GAC,
hence also explaining why it has never been possible to obtain an
atomic resolution structure including the termini [10,15]. For
reference, a secondary structure prediction of the N- and C-
termini is shown in Figure S18 in File S1, demonstrating little
prediction of secondary structural elements in accordance with our
finding of structural flexibility in the termini. Importantly, we also
showed that the C-terminal plays a role in the regulation and
stabilization of the tetrameric state. This is evident, since the full-
length construct showed a much stronger tetramerization tenden-
cy than the GACDC construct. This makes it possible to also
suggest which oligomeric state is the enzymatically active state. If
the shift from lower to higher oligomers triggers enzymatic activity
the GACDC construct would show a higher catalytic rate than
GACwt. However, our data showed that GACwt has an overall
higher activity compared to the GACDC construct. The tendency
is most clear for the inorganic phosphate screen where GACDC
formed much higher oligomers compared to the wildtype
construct. A construct similar to GACDC (D539–603, GACDC
is D556–603) has been shown to have an increased Km compared
to GACwt in the presence of inorganic phosphate [10]. Together,
this indicates that the tetrameric state is more enzymatically active
than the higher oligomers both in the presence and (to a lesser
extent) in the absence of inorganic phosphate.
It has been suggested that the C-terminal of GAC plays a role in
catalysis rate [10]. Likewise, GAC has a higher catalytic rate than
KGA and the only difference between the two isoforms is the C-
terminal. It has previously been speculated that the GAC N- and
C-terminal may interact directly with the active site [25,26]. Here,
we show that the C-terminal is flexible in vitro, principally in
accordance with this theory, since the flexibility may enable
transient interaction with the site. It is also possible that transient
interactions between two flexible C-termini provide an overall
stabilization of the dimer, and it could even be speulated that the
flexible tails partly prevent octamerization (based on the indication
that octamers form in an elongating direction, see Figure S10 in
File S1 for TEM images). These are, however, loose indications,
and it remains elusive how the tetramer state would be stabilized
by the C-terminal, which is placed far from the tetramerization
interface. It has also been suggested that the N-terminal
participates in transcription regulation and the terminal is shown
to play an important role in protein structure and activity
[9,10,15]. Again, the flexibility of the N-terminal that is
demonstrated in this study is well in accordance with the existence
of possible binding partners for regulatory purpose [27].
The N- and C-termini were shown to be highly flexible and
rather extended. Hence, the presented rigid body model of the full
length glutaminase C tetramer including the previously structur-
ally undescribed C- and N-termini represents an average solution
conformation, again emphasizing the flexible and extended nature
of the N- and C-termini. For comparison, representative models
generated by EOM both for GACwt and GACDC are shown in
Figure S16 in File S1. The selected models giving the best fit to the
experimental data clearly reveal the high flexibility.
It should be questioned whether the in vitro observations of
oligomers larger than tetramers (observed here by both TEM,
SEC-MALS and SAXS) are directly relevant for in vivo conditions.
In the living cell, the local concentration of GAC is expectedly
lower than those applied in the in vitro measurements, while the
overall concentration of macromolecules is significantly higher (the
effect commonly referred to as macromolecular crowding). A
range of specific protein partners may further influence the in vivo
solution state. Hence, great care should be taken before directly
infering in vivo relevance to the larger oligomeric species. However,
it is very tempting to suggest that the qualitatively consistent
observations from all applied methods (TEM, AUC, MALS and
SAXS), clearly revealing that GAC oligomeric state is highly
responsive to a number of experimental paramters (here: protein
concentration, surface interactions, phosphate concentrations,
presence/absence of C-terminal and equilibration time) has some
functional relevance, also in vivo. It seems plausible that regulation
of GAC activity involves changes in the oligomeric state, in
response to in vivo conditions (such as local phosphate concentra-
tions, presence of protein partners, phosphorylation and regulation
of GAC expression level). We hence suggest that our observations
of responsive changes in the oligomeric state reflects (one of) the
in vivo regulation(s) of GAC enzymatic activity.
In conclusion, a structural solution description of the full-length
tetrameric GAC enzyme, including the hitherto undescribed N-
and C-termini are presented. This tetramer exists in equilibrium
with both lower and higher oligomeric states, and the structural
analysis has only been possible by applying a microfluidic solution
SAXS setup, collecting SAXS data under numerous of exper-
imental conditions. Our detailed analysis of the SAXS data are
supplemented by both AUC and MALS data, hence providing a
confirmation of the existence of different oligomeric states. From
the SAXS data it is possible to link the observations between high
concentrations of Pi and enzymatic activity, with the existence of
tetramers in solution. Both protein concentration and the presence
of inorganic phosphate directly influences the distribution of
different oligomeric states in solution, and thus the enzymatic
activity. We hence have provided extensive structural analysis of a
highly complex enzymatic system, exhibiting a combination of
both structural flexibility and oligomeric development.
Materials and Methods
Design of Microfluidic Mixing System
The measurements were carried out using a fully automated
high-throughput microfluidic-mixing chip with a mixing design
similar to the design described previously [16,17]. The system
facilitated automated exposures on samples whose buffer or
concentration could be changed on the fly. A strong polystyrene
(PS) to polymethylmethacrylate (PMMA) bonding procedure was
developed to reduce the risk of leaks when utilizing the
microfluidic chip. A novel holder was designed for the chip that
not only ensured vacuum all the way to the exposure cell windows,
but also incorporated a boroscope linked to a video monitor that
made visual inspection of the sample possible during measure-
ments. The sample temperature was regulated using a commercial
chiller, which circulated water through the sample block. The
microfluidic chips were sealed to vacuum using a special o-ring
based clamping system. For detailed description of the mixing chip
setup, the holder, performance and construction information,
please refer to Figure S1–S4 in File S1. The microfluidic mixing
setup, allowing rapid screens of a given protein in various buffer
solutions, was used in order to perform screens of the GAC
solution behavior.
Glutaminase C Expression and Purification
A plasmid encoding mouse GAC (residues 73–603 for GACwt
and residues 73–555 for GACDC) were cloned into a pET28a
vector and the proteins were expressed with an N-terminal
histidine tag. The proteins were purified using a Ni-column,
anion-exchange and gel-filtration chromatography. The tag was
cleaved using thrombin after the Ni-column purification. Both
constructs were kept in 20 mM Tris-HCl pH 8.5, 500 mM NaCl,
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0.5 mM TCEP and 1 mM sodium azide for MALS, SAXS, and
AUC measurements. For SAXS Pi titration experiments KH2PO4
(1 M KH2PO4, 20 mM Tris-HCl, 500 mM NaCl, 0.5 mM
TCEP and 1 mM sodium azide; pH 8.4) was added to the buffer.
GACwt and GACDC were both freshly purified prior to all
experiments and the gel filtration elution buffer was used as blank.
The solutions were kept cold at all times. For the SAXS
measurements an initial concentration of 1.2 mg/mL and
1.4 mg/mL respectively were used.
SAXS Data Collection
The microfluidic mixing setup was attached to the flight tubes
on the beamlines providing vacuum all the way to the sample
exposure windows. The system consumed roughly 30 mL sample
volume per mixed sample. Series of samples at different
concentrations with buffer measurements in-between were pro-
grammed in the control software for the microfluidic system and
were performed automatically, including automated exposures.
See File S1 for details.
The SAXS data collection for testing the performance of the
microfluidic mixing chip and setup was carried out at F2 station of
the Cornell High Energy Synchrotron Source (CHESS). F2 used
an energy of 9.88 keV and provided a flux of 96109 photons/sec
for a 2506250 mm beam. Samples examined at F2 were exposed
for 40 sec with no signs of radiation damage. BSA (purchased from
Sigma Aldric, USA) was dissolved in 50 mM HEPES pH 7.5 as
done previously [28]. The protein solution was kept cold at all
times and centrifuged at 14000 rev/min for 20 min prior to data
collection.
A concentration screen of GACwt in the range 12 mM–73 mM
and of GACDC in the range 14 mM–98 mM was done. The Pi
titration screens were carried out from 0–100 mM Pi for both
constructs where GACwt protein concentration was kept constant
at 30.7 mM and GACDC protein concentration was kept constant
at 33.8 mM. The SAXS measurements for GAC constructs were
done at station G1 at CHESS. G1 used an energy of 9.86 keV and
provided a flux of 3610‘11 photons/sec for a 2506250 mm beam.
Samples used at G1 were exposed for 20 sec. and showed no signs
of radiation damage. Signs of aggregation were seen after 60 sec.
Mixing times after addition of Pi or dilution of protein sample to
start of measurement were 36 sec. for all measurements. Data
reduction and background subtraction were done using the RAW
data reduction software [29].
SAXS Data Treatment
Rg and I(0) values were estimated using the program RAW [29]
and the MWs were estimated using the forward scattering and
BSA. When defining the Guinier range the smax*Rg values were
always maintained in the range 1.28–1.31. All theoretical Rg
values of 3D models used throughout the SAXS data evaluation
for comparison with the experimental values were calculated using
the CRYSOL program [30] from the ATSAS suite [19,22,31].
The theoretical Rg (57.5 A˚) for the GACwt tetramer was
calculated from the SASREFMX derived model. SAXS data
were collected on a GAC construct mutated in the dimer-dimer
interface, which traps the protein as a dimer (Y. Li, et al., in
preparation) (a GACwt dimer). An Rg value of 41.64 A˚ was
estimated from a scattering curve collected on this GACwt dimer
construct. Rg values for the manually built octamer and 16mer are
94.7 A˚ and 186.5 A˚ respectively. Rg for GACwt and GACDC
octamers and 16mers are estimated to be very similar within the
accuracy of SAXS data.
Rigid Body Modelling
Rigid body modelling as performed using the recently
developed program SASREFMX [19]. The method implemented
in SASREFMX performs rigid body modeling of multisubunit
complexes and oligomeric assemblies against the scattering data
from polydisperse samples containing some amount of dissociation
products. The optimized parameters in this case are the positions
and orientations of the individual subunits (in terms of three
Cartesian shifts and three rotation angles) as well as the volume
fractions of the intact assembly and dissociation product(s). In the
present study, the rigid portion of the GAC monomer was fixed in
a position yielding the crystallographic tetramer upon application
of the P222 symmetry. The arrangements of four sets of the N-
and C-terminal portions in respect to the core were modeled in a
symmetric way and the volume fractions of the tetramer and the
dimer in solution were adjusted.
All eight scattering curves in the GACwtCS data set were
applied. Furthermore, a scattering curve of the above mentioned
GAC construct mutated in the dimer-dimer interface (the GACwt
dimer) was used for the rigid body modelling and the tetrameric
crystal structure of GACwt (3ss3.pdb) [10]. Default settings were
used when running the program. During the analysis we
calculated both models including all GACwtCS scattering curves,
models excluding the GACwtCS scattering concentration curves
at low concentrations and models excluding the high concentra-
tion GACwtCS scattering curves. Models were also calculated
multiple times using different starting-points for the N-terminal
and the C-terminal to reduce the effect of a particular random
conformation. The models generated in individual runs demon-
strated similar overall appearance.
MALS Data Collection and Data Treatment
Purified protein was subjected to size exclusion chromatography
(SEC) using a WTC-030S5 column (Wyatt Technology) equili-
brated in 20 mM Tris-HCl pH 8.5, 500 mM NaCl (GF buffer) at
a temperature of 23uC. For the concentration screen, K2HPO4
was absent, while protein concentration was varied within the
range 1.4–9.7 mM. For the Pi screen, protein concentration was
constant at 5 mM in the peak (injected concentration was 70 mM)
while varying concentrations of K2HPO4 up to 100 mM. The size
exclusion column was equilibrated in the GF buffers containing
varying concentrations of K2HPO4 (0, 25, 50, and 100 mM). The
SEC was coupled to a static 18-angle light scattering detector
(DAWN HELEOS-II) and a refractive index detector (Optilab T-
rEX, Wyatt Technology) was connected downstream of the SEC
column. The SEC flow rate was 1 mL/min. Data was analyzed
using the program ASTRA to obtain the RMS radius and mass
distribution (polydispersity) of the samples. Monomeric BSA
(Sigma) was used to normalize the light scattering signal and the
refractive index values were used to obtain protein concentrations.
RMS radius values plotted on the x-axis in Figure 4a–b were taken
as an average of the detected RMS radius, with outliers excluded.
AUC Data Collection and Data Treatment
Analytical ultracentrifugation experiments were performed on a
Beckman XL-I analytical ultracentrifuge. Prior to loading of the
protein samples, the centrifuge chamber, rotor and assembled cells
were equilibrated at 4uC to minimize protein aggregation. All
sedimentation experiments were performed at 4uC and the protein
sedimentation was monitored at 280 nm at a rotor speed of
50000 rpm. The data was analyzed using a c(S) model
implemented by SEDFIT [32]. The partial specific volume was
calculated using Sednterp [33].
Glutaminase C Solution Behavior
PLOS ONE | www.plosone.org 11 September 2013 | Volume 8 | Issue 9 | e74783
Flexibility
Flexibility was assessed with Ensemble Optimization Method
(EOM) [19,21] which assumes coexistence of a range of
conformations in solution for which an average scattering intensity
fits the experimental SAXS data. A revised version of EOM
[19,21] was used to create a pool of 30,000 independent models
for which the theoretical scattering curves are computed using
CRYSOL [34] (exhibiting 10,000 dimeric, 10,000 tetrameric and
10,000 octameric conformations for the GACwtCS as well as for
the GACDCC). Afterwards, a genetic algorithm was used to select
an ensemble of conformations with average theoretical profile
fitting the experimental SAXS data. The genetic algorithm was
repeated 100 times and the ensemble with the lowest discrepancy
was reported as the best solution out of 100 final ensembles. In
order to distinguish between EOM models that show dimeric,
tetrameric and octameric oligomerization, an Rg histogram was
calculated using all the models in the selected ensembles. Outcome
Rg distributions for the selected ensembles were then compared to
the Rg distribution of the pool in order to identity the
oligomerization fraction.
EOM does not have any limitation of the linker length and thus
the full flexible N- and C-termini were modeled. The 3ss3.pdb
tetramer structure of GAC [10] was used as core. The 3ss3.pdb
only has structural information for the amino acid sequence 145–
549; therefore the rest of the structure was modeled by EOM as
potentially flexible parts. The theoretical scattering curve was
computed for each model in the pool by CRYSOL [34]. P222
symmetry was applied for the tetramer and the octamer was
manually made considering a dimer and applying p222 symmetry.
Afterwards, the genetic algorithm selected ensembles of a varying
number of conformers (from 2 to 40) by calculating the average
theoretical profile and fitting it to the experimental SAXS data.
The genetic algorithm was repeated 100 times and the ensemble
with the lowest discrepancy (chi) was reported as the best solution
out of 100 final ensembles for each concentration in the series.
EOM selected monomer, dimer and tetramer models are shown in
Figure S16 in File S1.
Oligomerization Analysis Performed Using the Program
OLIGOMER
The scattering profile from an equilibrium mixture without
inter-particle interactions is a linear combination of the scattering






If the scattering patterns of the mixture components Ik are
available (or if their models are known), the values of nk can be
directly computed from the SAXS data by the program
OLIGOMER [35], using a linear least squares fitting. In the
present study OLIGOMER was applied to find the volume
fractions of the dimer, tetramer and octamers (where applicable).
In all SAXS-based modeling approaches presented here an
appropriate scaling of the predicted intensity curve is performed to











where c is a scaling factor, N is the number of points and s denotes
the experimental errors. Optionally, a background constant may
also be adjusted to provide better fit at higher angles. All four
datasets presented in the paper were analyzed (GACwtCS,
GACwtPS, GACDCCS and GACDCPS) and applied on the most
frequent models selected by EOM. From each EOM run the 10
most often selected models were chosen, generating a pool of 80
models for GACDC and 70 models for GACwt. Among these
structures the most typical structures were choosen to respresent a
broad range of Rg values (both extended and more compact
structures). For GACDC, the Rg values for dimers included in the
analysis were 38.5 A˚, 45.0 A˚ and 40.2 A˚. The Rg values for
tetramers included are 55.6 A˚ and 45.2 A˚. For GACwt, the Rg
values for dimers included in the analysis were 43.7 A˚, 41.1 A˚ and
32.3 A˚. The Rg values for tetramers included were 62.8 A˚ and
65.0 A˚. Also, manually built octamer (Rg = 91.4 A˚) and 16-mer
structures (Rg = 157.1 A˚) were included in the analysis. The
octamer and 16-mer are shown in Figure S11 in File S1.
OLIGOMER program was always run including the possibility for
background constant adjustment. All constants derived upon
analysis of the four datasets remained in the volume fractions
range 0.000–0.008.
GAC Activity Assay Protocol
The activity of GAC towards glutamine was measured by a two-
step coupled assay. In the first step, GAC was added to a buffer
(65 mM Tris-acetate (pH 8.6) and 0.2 mM EDTA) containing
20 mM glutamine and various concentrations of K2HPO4. This
mixture was incubated at RT for 10 min. and the reaction was
quenchd by addition of ice-cold hydrochloric acid (HCl) to a final
concentration of 0.3 M. An aliquot of this was added to a buffer
(160 mM Tris-HCl (pH 9.4)) containing 0.35 mM adenosine
diphosphate, 1.7 mM nicotinamide adenine dinucleotide (NAD)
and 6.3 U/mL glutamate dehydrogenase and incubated at RT for
50 min. Subsequently, the absorbance at 340 nm was measured
and converted to glutamate concentrations using the extinction
coefficient for the conversion of NAD to NADH of
6220 M21cm21.
Supporting Information
File S1 Supporting information figures and tables.
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